Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824. doi: 10.1164/rccm.2009-040GL.
This document is an international evidence-based guideline on the diagnosis and management of idiopathic pulmonary fibrosis, and is a collaborative effort of the American Thoracic Society, the European Respiratory Society, the Japanese Respiratory Society, and the Latin American Thoracic Association. It represents the current state of knowledge regarding idiopathic pulmonary fibrosis (IPF), and contains sections on definition and epidemiology, risk factors, diagnosis, natural history, staging and prognosis, treatment, and monitoring disease course. For the diagnosis and treatment sections, pragmatic GRADE evidence-based methodology was applied in a question-based format. For each diagnosis and treatment question, the committee graded the quality of the evidence available (high, moderate, low, or very low), and made a recommendation (yes or no, strong or weak). Recommendations were based on majority vote. It is emphasized that clinicians must spend adequate time with patients to discuss patients' values and preferences and decide on the appropriate course of action.
本文件是关于特发性肺纤维化诊断和管理的国际循证指南,由美国胸科学会、欧洲呼吸学会、日本呼吸学会和拉丁美洲胸科协会共同制定。它代表了目前关于特发性肺纤维化(IPF)的知识状况,内容包括定义和流行病学、危险因素、诊断、自然史、分期和预后、治疗以及监测疾病过程。对于诊断和治疗部分,采用基于问题的实用 GRADE 循证方法学。对于每个诊断和治疗问题,委员会对现有证据的质量进行分级(高、中、低或极低),并提出建议(是或否,强或弱)。建议基于多数票。需要强调的是,临床医生必须与患者充分沟通,讨论患者的价值观和偏好,并决定适当的治疗方案。